Related Experiment Video

Updated: Jul 2, 2026

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
03:45

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model

Published on: August 8, 2022

[Obstructive hypertrophic cardiomyopathy]

Celso Mendoza-González1, Francisco Javier Roldán, Zaira García López

  • 1Instituto Nacional de Cardiología Ignacio Chávez, Tlalpan, México, DF. celame@yahoo.com.mx

Archivos De Cardiologia De Mexico
|August 30, 2008
PubMed

Insights

Hypertrophic cardiomyopathy (HCM) is characterized by unexplained heart muscle thickening. Advanced echocardiography precisely identified septal hypertrophy and dynamic left ventricular outflow tract obstruction in a patient, guiding treatment.

Area of Science:

  • Cardiology
  • Medical Imaging
  • Electrophysiology

Background:

  • Hypertrophic cardiomyopathy (HCM) involves unexplained myocardial hypertrophy.
  • Accurate localization of hypertrophy and outflow tract obstruction is crucial for treatment strategy.

Observation:

  • A 41-year-old man presented with palpitations, EKG showing left ventricular hypertrophy, and echocardiogram revealing HCM and mitral regurgitation.
  • Long-term EKG monitoring showed evolving changes related to left ventricular hypertrophy and systolic overload.
  • Three-dimensional echocardiography visualized dynamic left ventricular outflow tract obstruction.

Findings:

  • Electrophysiological study under amiodarone did not induce ventricular arrhythmias.
  • Hemodynamic study confirmed a subaortic gradient, increasing with post-extrasystolic beats (Brockenbrough-Braunwald phenomenon).
  • Three-dimensional echocardiography accurately defined the septal hypertrophy site and its hemodynamic impact.

Implications:

  • Precise anatomical and functional characterization of HCM is vital for effective management.
  • Advanced imaging techniques like 3D echocardiography enhance diagnostic accuracy in complex cardiac conditions.
  • Understanding dynamic obstruction mechanisms aids in tailoring therapeutic interventions for hypertrophic cardiomyopathy.

More Related Videos

An Approach to Study Shape-Dependent Transcriptomics at a Single Cell Level06:02

An Approach to Study Shape-Dependent Transcriptomics at a Single Cell Level

Published on: November 2, 2020

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...